High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load
Open Access
- 20 December 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 10 (1), 358-6
- https://doi.org/10.1186/1471-2334-10-358
Abstract
Concomitant infections may influence HIV progression by causing chronic activation leading to decline in T-cell function. In the Americas, visceral (AVL) and tegumentary leishmaniasis (ATL) have emerged as important opportunistic infections in HIV-AIDS patients and both of those diseases have been implicated as potentially important co-factors in disease progression. We investigated whether leishmaniasis increases lymphocyte activation in HIV-1 co-infected patients. This might contribute to impaired cellular immune function. To address this issue we analyzed CD4+ T absolute counts and the proportion of CD8+ T cells expressing CD38 in Leishmania/HIV co-infected patients that recovered after anti-leishmanial therapy. We found that, despite clinical remission of leishmaniasis, AVL co-infected patients presented a more severe immunossupression as suggested by CD4+ T cell counts under 200 cells/mm3, differing from ATL/HIV-AIDS cases that tends to show higher lymphocytes levels (over 350 cells/mm3). Furthermore, five out of nine, AVL/HIV-AIDS presented low CD4+ T cell counts in spite of low or undetectable viral load. Expression of CD38 on CD8+ T lymphocytes was significantly higher in AVL or ATL/HIV-AIDS cases compared to HIV/AIDS patients without leishmaniasis or healthy subjects. Leishmania infection can increase the degree of immune system activation in individuals concomitantly infected with HIV. In addition, AVL/HIV-AIDS patients can present low CD4+ T cell counts and higher proportion of activated T lymphocytes even when HIV viral load is suppressed under HAART. This fact can cause a misinterpretation of these laboratorial markers in co-infected patients.Keywords
This publication has 36 references indexed in Scilit:
- GB virus type C infection modulates T-cell activation independently of HIV-1 viral loadAIDS, 2009
- High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin TreatmentJournal of Virology, 2009
- Human Herpesvirus Replication and Abnormal CD8+ T Cell Activation and Low CD4+ T Cell Counts in Antiretroviral-Suppressed HIV-Infected PatientsPLOS ONE, 2009
- Emerging Concepts in the Immunopathogenesis of AIDSAnnual Review of Medicine, 2009
- Down‐Regulation of Interleukin‐7 Receptor (CD127) in HIV Infection Is Associated with T Cell Activation and Is a Main Factor Influencing Restoration of CD4+Cells after Antiretroviral TherapyThe Journal of Infectious Diseases, 2008
- Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasisCurrent Opinion in Infectious Diseases, 2008
- The Relationship between Leishmaniasis and AIDS: the Second 10 YearsClinical Microbiology Reviews, 2008
- CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjectsMedical Microbiology and Immunology, 2007
- T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after TherapyClinical and Vaccine Immunology, 2002
- Immune activation is a dominant factor in the pathogenesis of African AIDSImmunology Today, 1995